These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial. Serebruany VL, Malinin AI, Pokov AN, Hanley DF. Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263 [Abstract] [Full Text] [Related]
3. Aspirin non-responders in Thai ischemic stroke/TIA patients. Dharmasaroja P. J Med Assoc Thai; 2008 Jun; 91(6):818-21. PubMed ID: 18697379 [Abstract] [Full Text] [Related]
4. The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study: baseline characteristics of the population. Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox K, Hennerici M, Mattle HP, Rothwell PM, PERFORM Study Investigators. Cerebrovasc Dis; 2009 Jun; 27(6):608-13. PubMed ID: 19407444 [Abstract] [Full Text] [Related]
5. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected]. Kirshner HS. Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660 [Abstract] [Full Text] [Related]
6. Clinical inquiries. What is the best management for patients who have a TIA while on aspirin therapy? Ahmed N, Coffey JB, Oh R. J Fam Pract; 2006 Jul; 55(7):627-8. PubMed ID: 16822451 [Abstract] [Full Text] [Related]
10. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy. Biller J. J Neurol Sci; 2009 Sep 15; 284(1-2):1-9. PubMed ID: 19380153 [Abstract] [Full Text] [Related]
11. Enhanced ex vivo inhibition of platelet function following addition of dipyridamole to aspirin after transient ischaemic attack or ischaemic stroke: first results from the TRinity AntiPlatelet responsiveness (TrAP) study. Tobin WO, Kinsella JA, Collins DR, Coughlan T, O'Neill D, Egan B, Tierney S, Feeley TM, Murphy RP, McCabe DJ. Br J Haematol; 2011 Mar 15; 152(5):640-7. PubMed ID: 21223254 [Abstract] [Full Text] [Related]
15. [Factors associated to aspirin failure for secondary stroke prevention]. Chamorro A, Blanc R, Ascaso C, Saiz A, Vila N. Med Clin (Barc); 1997 Nov 01; 109(15):569-72. PubMed ID: 9441190 [Abstract] [Full Text] [Related]